rs750639846
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_144670.6(A2ML1):c.462+16_462+18delGAG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000681 in 1,614,080 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_144670.6 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
A2ML1 | ENST00000299698.12 | c.462+9_462+11delGGA | intron_variant | Intron 4 of 35 | 1 | NM_144670.6 | ENSP00000299698.7 | |||
A2ML1-AS1 | ENST00000537288.1 | n.286+872_286+874delTCC | intron_variant | Intron 1 of 1 | 3 | |||||
A2ML1 | ENST00000537546.1 | n.286+9_286+11delGGA | intron_variant | Intron 3 of 3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152150Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00135 AC: 337AN: 249488Hom.: 3 AF XY: 0.00177 AC XY: 240AN XY: 135348
GnomAD4 exome AF: 0.000702 AC: 1026AN: 1461812Hom.: 8 AF XY: 0.000980 AC XY: 713AN XY: 727192
GnomAD4 genome AF: 0.000479 AC: 73AN: 152268Hom.: 0 Cov.: 31 AF XY: 0.000618 AC XY: 46AN XY: 74456
ClinVar
Submissions by phenotype
not provided Benign:3
- -
A2ML1: BS2 -
- -
not specified Benign:1
Variant summary: A2ML1 c.462+16_462+18delGAG alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0014 in 249488 control chromosomes in the gnomAD database, including 3 homozygotes. The observed variant frequency is more than 300 higher than the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome phenotype (4e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.462+16_462+18delGAG in individuals affected with Noonan Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at